Aarti Industries Ltd Stock Analysis

BSE: 524208 | NSE: AARTIIND | Chemicals | Large Cap

BSE Share Price 02-Dec-2022 18:01
674.15 -1.00 (-0.15%)

DeciZen - Make an Informed Decision on Aarti Inds

Overall Rating

1. Quality

2. Valuation

Fair

3. Price Trend

Aarti Inds Price Chart

P/E Ratio (CD) :
19.10
Market Cap :
24,438.2 Cr.
52-wk low :
642.1
52-wk high :
1,118.7
Bole Toh?

1. Is Aarti Industries Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Industries Ltd is a good quality company.

2. Is Aarti Industries Ltd undervalued or overvalued?

The key valuation ratios of Aarti Industries Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Aarti Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarti Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarti Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarti Industries Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 14.4%13.5%14.4%14.4%14.5%12.5%14%12%10.1%18.7%-
Value Creation Index 0.0-0.00.00.00.1-0.10.0-0.1-0.10.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2,0962,6322,9083,0073,1633,8064,1684,1864,5067,0007,789
YoY Gr. Rt. %-25.6%10.5%3.4%5.2%20.3%9.5%0.5%7.6%55.3%-
Adj EPS 4.24.45.77.79.610.114.215.21536.135.3
YoY Gr. Rt. %-3.8%28.9%35.8%24.7%5.2%40.1%7.5%-1.3%140%-
BVPS (₹) 23.824.628.734.141.548.575.985.5100.5163.1129.3
Adj Net Profit 1341562012573153294915305231,3071,280
Cash Flow from Ops. 2303153405744703357361,102873471-
Debt/CF from Ops. 3.73.33.52.33.36.23.31.93.35.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.3%17.2%18.9%55.3%
Adj EPS 26.9%30.3%36.6%140%
BVPS 23.931.529.162.3
Share Price 40% 24.3% 18.6% -29.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 19.919.221.323.825.222.323.318.916.127.824.1
Op. Profit Mgn % 17.215.3161920.718.423.223.421.827.624.9
Net Profit Mgn % 6.35.56.58.910.3912.112.911.918.716.4
Debt to Equity 1.11.21.21.11.21.30.90.70.80.40.2
Working Cap Days 191189187179161160153168161132149
Cash Conv. Cycle 907874818083809075693

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 24.10%

Sales growth is growing at healthy rate in last 3 years 18.87%

Net Profit is growing at healthy rate in last 3 years 36.58%

Debt to equity has declined versus last 3 years average to 0.44

Sales growth is good in last 4 quarters at 57.33%

No data to display

Latest Financials - Aarti Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 34.9 35.3
TTM Sales (₹ Cr.) 7,670 7,789
BVPS (₹.) 129 129.3
Reserves (₹ Cr.) 4,493 4,507
P/BV 5.23 5.21
PE 19.30 19.10
From the Market
52 Week Low / High (₹) 642.10 / 1118.65
All Time Low / High (₹) 0.64 / 1168.40
Market Cap (₹ Cr.) 24,438
Equity (₹ Cr.) 181.3
Face Value (₹) 5
Industry PE 34.1

Management X-Ray of Aarti Inds :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.010.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aarti Inds

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Aarti Industries Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aarti Inds on 02-Dec-2022 18:01 is : 674.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Dec-2022 18:01 the market cap of Aarti Inds stood at ₹ 24,438.2.
The latest PE ratio of Aarti Inds as of 02-Dec-2022 18:01 is 19.30.
The latest PB ratio of Aarti Inds as of 02-Dec-2022 18:01 is 5.23
The 52-week high of Aarti Inds is ₹ 1,118.7 and the 52-week low is ₹ 642.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Aarti Inds is ₹ 7,670 ( Cr.) .

About Aarti Industries Ltd

Aarti Industries Limited is listed entity incorporated in India. Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals manufactured by the company are used in the downstream manufacture of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes, etc.

Business area of the company

Aarti Industries is engaged in manufacturing and dealing in speciality chemicals and pharmaceuticals.

Products offered by the company

Chemical products

  • Chlorination 
  • Nitration 
  • Hydrogenation 
  • Ammonolysis 
  • Halex 
  • Dinitro chlorination 
  • Alkylation 
  • Hydrolysis 
  • Methoxylation 
  • Esterification 
  • Diazaotiation 
  • Sulphonation 
  • Condensation 
  • N-Alkylation 
  • Oxidation 
  • Other (inorganic)

Pharma

Anti Hypertensive

  • Ramipril 
  • Quinapril HCL 
  • Benazepril HCL 
  • Benazepril HCL Polymorph B 
  • Perindopril Tert-butylamine 
  • Perindopril Arginine 
  • Ranolazine Di-HCL / Base

Anti Asthamatic

  • Budesonide 
  • Bambuterol HCL 
  • Salmeterol Xinafoate 
  • Ipratropium Bromide 
  • Ciclesonide 
  • Fluticasone Propionate 
  • Fluticasone Furoate 
  • Mometasone Furoate Monohydrate 
  • Formoterol Fumarate 
  • Montelukast Sodium

Anti Cancer

  • Bicalutamide 
  • Ifosfamide 
  • Ifosfamide Sterile 
  • Cyclophosphamide 
  • Cyclophosphamide Sterile 
  • Mesna 
  • Mercaptopurine 
  • Azathioprine 
  • Capecitabine
  • R-Salbutamol Sulphate 
  • Levalbuterol HCL 
  • Levalbuterol Tartrate

Milestones

1984

  • Incorporated Aarti Organics Private Limited.

1986

  • Commenced 1,200 Tonnes Per Annum (TPA) unit for Nitro Chloro Benzenes (NCB) in Sarigram, Gujarat.

1990

  • Set up the first large-scale organic plant in Vapi - 4,500 TPA unit for NCB.

2001

  • Set up a large-scale hydrogenation and nitration unit at Jhagadia (hydrogen gas via pipeline).

2005-08

  • Expanded the NCB and sulphuric acid capacity.
  • Set up a large-scale speciality chemical unit in Kutch.
  • Received US FDA approval for an Active Pharmaceutical Ingredient (API) unit in Tarapur.

2011

  • Upgraded the hydrogenation unit from batch to continuous.
  • Received USFDA approval for the custom synthesis division at Vapi.
  • Commenced bulk shipment for global markets.

2016

  • Commissioned an ethylation facility at Dahej SEZ (ethylene gas via pipeline).
  • Expanded the NCB capacity from 57 KTPA to 75 KTPA.

2017

  • Commenced the functioning of the calcium chloride facility.
  • Started operations at co-generation and solar power plants.

2018

  • Commissioned the Nitro Toulene plant.
  • Signed two large multi-year contracts with global players.
  • Manufacturing facility being set up at Dahej SEZ.

2019

  • Commissioned the Nitro Toulene hydrogenation facility at Jhagadia.
  • Signed another multi-year contract with a global player.

2020

  • Operationalised Aarti Research and Technology Centre (ARTC) at Mahape, Navi Mumbai.
  • Commissioned two units at Dahej SEZ for high-value speciality chemicals.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now